Navigation Links
Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
Date:5/31/2012

SAN DIEGO, May 31, 2012 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) will be presenting at the Jefferies 2012 Global Healthcare Conference in New York on Thursday, June 7, 2012 at 12:30 p.m. ET/9:30 a.m. PT. Kurt Gustafson, Chief Financial Officer, Halozyme Therapeutics, will provide a corporate overview.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

The presentation will be webcast through the "Investors" section of Halozyme's corporate website at www.halozyme.com, and a recording will be made available for 90 days following the event. To access the live webcast, please log on to Halozyme's website approximately fifteen minutes prior to the presentation to register and download any necessary audio software.

About Halozyme

Halozyme Therapeutics is a biopharmaceutical company dedicated to developing and commercializing innovative products that advance patient care. With a diversified portfolio of enzymes that target the extracellular matrix, the Company's research focuses primarily on a family of human enzymes, known as hyaluronidases, that increase the absorption and dispersion of biologics. Halozyme's pipeline addresses therapeutic areas, such as diabetes, oncology and dermatology that have significant unmet medical need. The Company markets Hylenex® recombinant (hyaluronidase human injection) and has partnerships with Roche, Baxter, ViroPharma and Intrexon. Halozyme is headquartered in San Diego, CA. For more information on how we are innovating, please visit our corporate website at www.halozyme.com.

Media/Investor Contact:
Anne Erickson
Executive Director
Halozyme Therapeutics
858-704-8264
aerickson@halozyme.com


'/>"/>
SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Halozyme Reports First Quarter 2012 Financial Results
2. Halozyme to Host First Quarter 2012 Financial Results Conference Call
3. ViroPharma and Halozyme Announce Positive Data of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Recombinant Human Hyaluronidase (rHuPH20)
4. Halozyme Therapeutics to Present at the CITI 2012 Global Healthcare Conference
5. Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock
6. Halozyme Announces Proposed Public Offering of Common Stock
7. ViroPharma and Halozyme Therapeutics Announce Positive Data From Initial Phase 2 Assessment of Subcutaneous Cinryze® (C1 esterase inhibitor [human]) with Hyaluronidase (rHuPH20)
8. Halozyme Therapeutics Announces Positive Results From Enzyme-Augmented Insulin Pump Trial
9. Halozyme Therapeutics to Present Data on PEGPH20 at the Upcoming 2011 EORTC-NCI-ASCO Annual Meeting
10. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
11. Halozyme Begins Randomized, Controlled Clinical Trial with PEGPH20 in Patients with Advanced Pancreatic Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2020)... ... April 01, 2020 , ... As ... provider of urgent care and accessible primary care, launches its telemedicine platform, AFC/TeleCare, ... healthcare clinics will now provide virtual visits, allowing our medical providers to easily ...
(Date:3/30/2020)... , ... March 30, 2020 , ... ... its employees, today announced it has launched a series of survey question packs ... gather actionable feedback to inform mission-critical decisions. As the current situation continues to ...
(Date:3/30/2020)... ... 30, 2020 , ... Representatives with Miami-based Tattoo Vanish ... service. , "We are very excited to offer this service," said Barbara Gonzalez, ... Institute of Tattoo Removal is available to answer any questions or concerns regarding ...
Breaking Medicine Technology:
(Date:4/1/2020)... ... April 01, 2020 , ... ... stay safe while treating Coronavirus-infected patients. , Staffers are in particular need of ... coronavirus. Earlier this week, The Wall Street Journal reported that New York City ...
(Date:3/30/2020)... ... 30, 2020 , ... Frontline Public Safety Solutions is living ... effort to keep frontline officers and the public safe in the face of ... minimizing direct contact. They are also freeing up 911 lines for genuine emergencies ...
(Date:3/28/2020)... NEW YORK (PRWEB) , ... March 27, 2020 ... ... Mediaplanet today announces the launch of this March’s edition of “The Fertility Journey.” ... changing the face of fertility, third-party parenting, and maternal health options. , ...
(Date:3/27/2020)... ... March 27, 2020 , ... NeoTract, a wholly ... field of urology, today announced that Harpreet Wadhwa, M.D., East Valley Urology Center ... designation recognizes that Dr. Wadhwa has achieved a high level of training and ...
(Date:3/22/2020)... ... March 22, 2020 , ... “At a time when the public is being ... Health Insurance Solutions’ First Stop Health Telemedicine program is a valuable resource ... Health Telemedicine program, is a valuable tool that can help Americans in their fight ...
Breaking Medicine News(10 mins):